Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Pierluigi Paggiaro, Simona Barbaglia, Stefano Centanni, Davide Croce, Enrico Desideri, Saffi Giustini, Claudio Micheletto, Antonino Musarra, Nicola Scichilone, Ugo Trama, Maria Teresa Zedda & Giorgio Walter Canonica. (2021) Overcoming Barriers to the Effective Management of Severe Asthma in Italy. Journal of Asthma and Allergy 14, pages 481-491.
Read now
Read now
Marco Caminati, Rachele Vaia, Fabiana Furci, Gabriella Guarnieri & Gianenrico Senna. (2021) Uncontrolled Asthma: Unmet Needs in the Management of Patients. Journal of Asthma and Allergy 14, pages 457-466.
Read now
Read now
Francesco Menzella, Giulia Ghidoni, Matteo Fontana, Silvia Capobelli, Francesco Livrieri, Claudia Castagnetti & Nicola Facciolongo. (2021) The role of systemic corticosteroids in severe asthma and new evidence in their management and tapering. Expert Review of Clinical Immunology 17:12, pages 1283-1299.
Read now
Read now
Khalid Al Efraij, Kate M. Johnson, Darrin Wiebe, Mohsen Sadatsafavi & J. Mark FitzGerald. (2019) A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma. Journal of Asthma 56:12, pages 1334-1346.
Read now
Read now
Hector Ortega, Jean-Pierre Llanos, Marie-Helene Lafeuille, Mei Sheng Duh, Guillaume Germain, Dominique Lejeune, Susan Sama, Chris Bell & Beth Hahn. (2019) Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data. Journal of Asthma 56:8, pages 808-815.
Read now
Read now
Alicia Padilla Galo, Marina Labor, Angelica Tiotiu, Ilaria Baiardini, Nicola Scichilone & Fulvio Braido. (2018) Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives. Patient Related Outcome Measures 9, pages 267-273.
Read now
Read now
David B Price, Frank Trudo, Jaco Voorham, Xiao Xu, Marjan Kerkhof, Joanna Ling Zhi Jie & Trung N Tran. (2018) Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. Journal of Asthma and Allergy 11, pages 193-204.
Read now
Read now
Khalid Al Efraij & J. Mark FitzGerald. (2018) Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotype. Expert Review of Clinical Pharmacology 11:7, pages 669-676.
Read now
Read now
Manuela Latorre, Angela Rizzi, Pierluigi Paggiaro, Ilaria Baiardini, Diego Bagnasco, Stefano DelGiacco, Carlo Lombardi, Vincenzo Patella, Eleonora Nucera, Roberta Parente, Giovanni Paoletti, Laura Pini, Erminia Ridolo, Gianenrico Senna, Francesco Blasi, Giorgio
Walter Canonica, Arianna Aruanno, Carmen Ballacchino, Marco Bonavia, Cecilia Calabrese, Marco Caminati, Monica Carbonara, Cristina Cardini, Cristiano Caruso, Luciano Cattani, Maria
Angiola Crivellaro, Alessandra Diana, Eugenia Durante, Elisabetta Favero, Maria
Pia
Foschino Barbaro, Sandra Frateiacci, Gabriella Guarnieri, Alessia Lofaro, Francesca Losa, Nadia Magarò, Francesco Menzella, Luisa Ricciardi, Giulia Scioscia, Elisa Testino & Francesca Torracca. Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients. Journal of Asthma 0:0, pages 1-26.
Read now
Read now
Articles from other publishers (44)
Jeremiah Hwee, Lorraine Harper, Qinggong Fu, Krishnarajah Nirantharakumar, George Mu & Rupert W. Jakes. (2024) Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK. ERJ Open Research 10:3, pages 00430-2023.
Crossref
Crossref
Mona Al-Ahmad, Ashraf Al Zaabi, Ashraf Madkour, Haider Abdulhameed Alqaraghuli, Hajar Al Hayaan, Hassan Mobayed, Majdy Idrees, Nasser Al busaidi & Salah Zeineldine. (2024) Expert Consensus on Oral Corticosteroids Stewardship for the Treatment of Severe Asthma in the Middle East and Africa. Respiratory Medicine, pages 107674.
Crossref
Crossref
Thomas B Casale, Thomas Corbridge, Guillaume Germain, François Laliberté, Sean D MacKnight, Julien Boudreau, Mei S Duh & Arijita Deb. (2024) Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma. Allergy, Asthma & Clinical Immunology 20:1.
Crossref
Crossref
Laurent Guilleminault, Michael Mounié, Agnès Sommet, Claire Camus, Alain Didier, Laurent Lionel Reber, Cécile Conte & Nadège Costa. (2024) The economic burden of asthma prior to death: a nationwide descriptive study. Frontiers in Public Health 12.
Crossref
Crossref
David R.W. Jayne, Benjamin Terrier, Bernhard Hellmich, Paneez Khoury, Lee Baylis, Jane H. Bentley, Jonathan Steinfeld, Steven W. Yancey, Namhee Kwon, Michael E. Wechsler & Praveen Akuthota. (2024) Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics. ERJ Open Research 10:1, pages 00509-2023.
Crossref
Crossref
Cesar Fireth Pozo-Beltran, Barbara Elizondo-Villarreal, Fernando Morett-Vera, Victor Gonzalez-Uribe, Roxana Minerva Rodriguez-Romo, Elsy Maureen Navarrete-Rodriguez, Jorge Andres Paniagua-Santos, Jesus Fernando Ledezma-Ortega & Adriana Virginia Briceño-Gamboa. (2023) Severe Asthma Patients: Can We Really Wean Them off of Oral Corticosteroids. Current Treatment Options in Allergy 10:3, pages 215-231.
Crossref
Crossref
Alicia Padilla-Galo, Isabel Moya Carmona, Pilar Ausín, Luis Carazo Fernández, Ismael García-Moguel, José Luis Velasco-Garrido, Rubén Andújar-Espinosa, Francisco Casas-Maldonado, Eva Martínez-Moragón, Carlos Martínez Rivera, Elisabet Vera Solsona, Fernando Sánchez-Toril López, Andrea Trisán Alonso, Marina Blanco Aparicio, Marcela Valverde-Monge, Borja Valencia Azcona, Marta Palop Cervera, Javier Nuevo, Jesús Sánchez Tena, Gustavo Resler, Elisa Luzón & Alberto Levy Naon. (2023) Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study. Respiratory Research 24:1.
Crossref
Crossref
Heath Heatley, Trung N Tran, Arnaud Bourdin, Andrew Menzies-Gow, David J Jackson, Ekaterina Maslova, Jatin Chapaneri, Derek Skinner, Victoria Carter, Jeffrey Shi Kai Chan, Con Ariti, John Haughney & David B Price. (2023) Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma. Thorax 78:9, pages 860-867.
Crossref
Crossref
Wen Wang, Jieying Li, Congying Zou, Lifang Zhao, Ya Zhu, Yue Guo & Feiran Wang. (2023) Omalizumab for Chinese patients with moderate-to-severe allergic asthma in real-world clinical setting: a prospective, observational study. BMJ Open Respiratory Research 10:1, pages e001549.
Crossref
Crossref
Maral DerSarkissian, Yuqian M. Gu, Mei Sheng Duh, John Benson, Shirley P. Huang, Carlyne Averell, Jensen Vu, Min‐Jung Wang & Christopher F. Bell. (2023)
Clinical and Economic Burden in Patients With Systemic Lupus Erythematosus During the First Year After Initiating Oral Corticosteroids: A Retrospective
US
Database Study
. ACR Open Rheumatology 5:6, pages 318-328.
Crossref
Crossref
John Haughney, Trung N. Tran, Heath Heatley, Arnaud Bourdin, Andrew Menzies-Gow, David J. Jackson, Ekaterina Maslova, Jatin Chapaneri, Derek Skinner, Victoria Carter, Jeffrey Shi Kai Chan & David Price. (2023) Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma. npj Primary Care Respiratory Medicine 33:1.
Crossref
Crossref
Greg E. Davis, Robert S. Zeiger, Benjamin Emmanuel, Yen Chung, Trung N. Tran, Kristin A. Evans, Stephanie Chen, Rohit Katial, James L. Kreindler & Joseph Tkacz. (2022) Systemic Corticosteroid–related Adverse Outcomes and Health Care Resource Utilization and Costs Among Patients with Chronic Rhinosinusitis with Nasal Polyposis. Clinical Therapeutics 44:9, pages 1187-1202.
Crossref
Crossref
Hiroyuki Nagase, Jun Tamaoki, Takeo Suzuki, Yasuko Nezu, Shoko Akiyama, Ashley L. Cole, Shibing Yang, George Mu, Masayuki Katsumata, Masaki Komatsubara & Rafael Alfonso-Cristancho. (2022) Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan. Pulmonary Pharmacology & Therapeutics 75, pages 102130.
Crossref
Crossref
Ken-ei Sada, Yoshiki Kojo, Jolyon Fairburn-Beech, Keiko Sato, Shoko Akiyama, Melissa K Van Dyke & Isao Mukai. (2022) The prevalence, burden of disease, and healthcare utilization of patients with eosinophilic granulomatosis with polyangiitis in Japan: a retrospective, descriptive cohort claims database study. Modern Rheumatology 32:2, pages 380-386.
Crossref
Crossref
Thomas B. Casale, Autumn Burnette, Arnaud Bourdin, Peter Howarth, Beth Hahn, Alexandra Stach-Klysh & Sandhya Khurana. (2022) Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies. Therapeutic Advances in Respiratory Disease 16, pages 175346662211073.
Crossref
Crossref
Alexandrosz Czira, Monica Turner, Amber Martin, David Hinds, Helen Birch, Frances Gardiner & Shiyuan Zhang. (2022) A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma. Respiratory Medicine 191, pages 106670.
Crossref
Crossref
Mohsen Sadatsafavi, Amir Khakban, Hamid Tavakoli, Solmaz Ehteshami-Afshar, Larry D. Lynd & J. Mark FitzGerald. (2021) Trends in oral corticosteroids use in severe asthma: a 14-year population-based study. Respiratory Research 22:1.
Crossref
Crossref
C. Raherison-Semjen, L. Guilleminault, I. Billiart, C. Chenivesse, A. De Oliveira, A. Izadifar, A. Lorenzo, C. Nocent, J.P. Oster, M. Padovani, T. Perez, M. Russier, M. Steinecker & A. Didier. (2021) Mise à jour des recommandations (2021) pour la prise en charge et le suivi des patients asthmatiques adultes sous l’égide de la Société de pneumologie de langue française (SPLF) et de la Société pédiatrique de pneumologie et allergologie (SP2A). Version longue. Revue des Maladies Respiratoires 38:10, pages 1048-1083.
Crossref
Crossref
Diego Bagnasco, Pierluigi Paggiaro, Manuela Latorre, Chiara Folli, Elisa Testino, Arianna Bassi, Manlio Milanese, Enrico Heffler, Andrea Manfredi, Anna Maria Riccio, Laura De Ferrari, Francesco Blasi, Rikki Frank Canevari, Giorgio Walter Canonica, Giovanni Passalacqua, Gabriella Guarnieri, Vincenzo Patella, Foschino Barbaro Maria Pia, Giovanna Elisiana Carpagnano, Anna del Colle, Giulia Scioscia, Pelaia Gerolamo, Francesca Puggioni, Francesca Racca, Elisabetta Favero, Sandra Iannacone, Eleonora Savi, Marcello Montagni, Gianna Camiciottoli, Chiara Allegrini, Carlo Lombardi, Giuseppe Spadaro, Caterina Detoraki, Francesco Menzella, Carla Galeone, Patrizia Ruggiero, Monna Rita Yacoub, Alvise Berti, Nicola Scichilone, Carmen Durante, Maria Teresa Costantino, Chiara Roncallo, Mariachiara Braschi, Alice D’Adda, Erminia Ridolo, Massimo Triggiani, Roberta Parente, D’Amato Maria, Maria Vittoria Verrillo, Giovanni Rolla, Luisa Brussino, Agata Valentina Frazzetto, Zappa Maria Cristina, Marianna Lilli, Nunzio Crimi, Marco Bonavia, Angelo Guido Corsico, Amelia Grosso, Stefano Del Giacco, Margherita Deidda, Luisa Ricciardi, Stefania Isola, Francesca Cicero, Giuliana Amato, Federica Vita, Antonio Spanevello, Patrizia Pignatti, Francesca Cherubino, Dina Visca, Fabio Luigi Massimo Ricciardolo, Vitina Maria Anna Carriero, Francesca Bertolini, Pierachille Santus, Roberta Barlassina, Andrea Airoldi, Giuseppe Guida, Nucera Eleonora, Arianna Aruanno, Angela Rizzi, Cristiano Caruso, Stefania Colantuono, Gianenrico Senna, Marco Caminati, Alessandra Arcolaci, Andrea Vianello, Fulvia Chieco Bianchi, Maria Rita Marchi, Stefano Centanni, Simone Luraschi, Silvia Ruggeri, Rocco Rinaldo, Elena Parazzini, Cecilia Calabrese, Martina Flora, Lorenzo Cosmi, Linda Di Pietro, Enrico Maggi, Laura Pini, Luigi Macchia, Danilo Di Bona, Luca Richeldi, Carola Condoluci, Leonello Fuso, Matteo Bonini, Alessandro Farsi, Giulia Carli, Paolo Montuschi, Giuseppe Santini, Maria Elisabetta Conte, Elisa Turchet, Carlo Barbetta, Francesco Mazza, Simona D’Alo, Stefano Pucci, Maria Filomena Caiaffa, Elena Minenna, Luciana D'Elia, Carlo Pasculli, Vittorio Viviano, Paolo Tarsia, Joyce Rolo, Mariacarmela Di Proietto & Salvatore Lo Cicero. (2021) Severe asthma: One disease and multiple definitions. World Allergy Organization Journal 14:11, pages 100606.
Crossref
Crossref
Joan Reibman, Laren Tan, Chris Ambrose, Yen Chung, Pooja Desai, Jean-Pierre Llanos, Meghan Moynihan & Joseph Tkacz. (2021) Clinical and economic burden of severe asthma among US patients treated with biologic therapies. Annals of Allergy, Asthma & Immunology 127:3, pages 318-325.e2.
Crossref
Crossref
Francesco Menzella, Carla Galeone, Giulia Ghidoni, Patrizia Ruggiero, Maria D'Amato, Matteo Fontana & Nicola Facciolongo. (2021) The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review. Multidisciplinary Respiratory Medicine 16.
Crossref
Crossref
Jaideep Dhariwal, Andrew P. Hearn, Joanne E. Kavanagh, Gráinne d’Ancona, Linda Green, Mariana Fernandes, Louise Thomson, Cris Roxas, Brian D. Kent, Alexandra M. Nanzer & David J. Jackson. (2021) Real-World Effectiveness of Anti–IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization. The Journal of Allergy and Clinical Immunology: In Practice 9:6, pages 2315-2320.e1.
Crossref
Crossref
Patrick W. Sullivan, Vahram H. Ghushchyan, David P. Skoner, Jason LeCocq, Siyeon Park & Robert S. Zeiger. (2021) Complications and Health Care Resource Utilization Associated with Systemic Corticosteroids in Children and Adolescents with Persistent Asthma. The Journal of Allergy and Clinical Immunology: In Practice 9:4, pages 1541-1551.e9.
Crossref
Crossref
Christos V Chalitsios, Dominick E Shaw & Tricia M McKeever. (2021) Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies. Thorax 76:1, pages 21-28.
Crossref
Crossref
Hyun Lee, Sang‐Heon Kim, Byung‐Keun Kim, Youngsoo Lee, Hwa Young Lee, Ga‐Young Ban, Min‐Hye Kim, Joo‐Hee Kim, Jae‐Woo Kwon, So‐Young Park, Jae‐Woo Jung, So Young Park, Chan Sun Park, Chin Kook Rhee, Taehoon Lee, Jae‐Hyun Lee, So Ri Kim, Jong‐Sook Park, Heung‐Woo Park, Kwang Ha Yoo, Yeon‐Mok Oh, Young‐Il Koh, Byung‐Jae Lee, An‐Soo Jang, Sang‐Heon Cho, Hae‐Sim Park, Choon‐Sik Park, You Sook Cho & Ho Joo Yoon. (2020) Characteristics of Specialist‐Diagnosed Asthma‐COPD Overlap in Severe Asthma: Observations from the Korean Severe Asthma Registry (KoSAR). Allergy 76:1, pages 223-232.
Crossref
Crossref
Robert Zeiger, Patrick Sullivan, Yen Chung, James L. Kreindler, Nicole M. Zimmerman & Joseph Tkacz. (2020) Systemic Corticosteroid-Related Complications and Costs in Adults with Persistent Asthma. The Journal of Allergy and Clinical Immunology: In Practice 8:10, pages 3455-3465.e13.
Crossref
Crossref
Alexandra M. Nanzer, Jaideep Dhariwal, Joanne Kavanagh, Andrew Hearn, Mariana Fernandes, Louise Thomson, Cris Roxas, Linda Green, Grainne D'Ancona, Sangita Agarwal, Brian D. Kent & David J. Jackson. (2020) Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis. ERJ Open Research 6:4, pages 00451-2020.
Crossref
Crossref
Tim Harrison, Giorgio Walter Canonica, Geoffrey Chupp, Jason Lee, Florence Schleich, Tobias Welte, Antonio Valero, Kim Gemzoe, Aoife Maxwell, Sandra Joksaite, Shibing Yang, Peter Howarth & Melissa K. Van Dyke. (2020) Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis. European Respiratory Journal 56:4, pages 2000151.
Crossref
Crossref
Kazuto Matsunaga, Mitsuru Adachi, Hiroyuki Nagase, Tomoko Okoba, Nobuya Hayashi & Yuji Tohda. (2020) Association of low-dosage systemic corticosteroid use with disease burden in asthma. npj Primary Care Respiratory Medicine 30:1.
Crossref
Crossref
Alexandra M. Nanzer, Aqib Chowdhury, Asma Raheem, Cris Roxas, Mariana Fernandes, Louise Thomson, Linda Green, Jaideep Dhariwal, Grainne D'Ancona, Brian D. Kent, Philip A. Kelly & David J. Jackson. (2020) Prevalence and recovery of adrenal insufficiency in steroid-dependent asthma patients receiving biologic therapy. European Respiratory Journal 56:1, pages 1902273.
Crossref
Crossref
G. Mahay, P.-O. Girodet, C. Tummino & A. Didier. (2020) Traitements de palier 5 dans l’asthme. Revue des Maladies Respiratoires Actualités 12:1, pages S11-S14.
Crossref
Crossref
Eugene R. Bleecker, Andrew N. Menzies-Gow, David B. Price, Arnaud Bourdin, Stephen Sweet, Amber L. Martin, Marianna Alacqua & Trung N. Tran. (2020) Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management. American Journal of Respiratory and Critical Care Medicine 201:3, pages 276-293.
Crossref
Crossref
Hyun Lee, Jiin Ryu, Sung Jun Chung, Dong Won Park, Jang Won Sohn, Ho Joo Yoon & Sang-Heon Kim. (2020) Coexisting COPD Increases Mortality in Patients With Corticosteroid-Dependent Asthma: A Nationwide Population-Based Study. Allergy, Asthma & Immunology Research 12:5, pages 821.
Crossref
Crossref
Hyun Lee, Jiin Ryu, Eunwoo Nam, Sung Jun Chung, Yoomi Yeo, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon & Sang-Heon Kim. (2019) Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study. European Respiratory Journal 54:5, pages 1900804.
Crossref
Crossref
Arnaud Bourdin, Caroline Fabry-Vendrand, Juliette Ostinelli, Malik Ait-Yahia, Elsa Darnal, Stéphane Bouee, Caroline Laurendeau, Isabelle Bureau, Julie Gourmelen & Christos Chouaid. (2019) The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database. The Journal of Allergy and Clinical Immunology: In Practice 7:5, pages 1477-1487.
Crossref
Crossref
Enrico Heffler, Diego Bagnasco & Giorgio W. Canonica. (2019) Strategies to reduce corticosteroid-related adverse events in asthma. Current Opinion in Allergy & Clinical Immunology 19:1, pages 61-67.
Crossref
Crossref
Woo-Jung Song, Ji-Hyang Lee, Yewon Kang, Woo Joung Joung & Kian Fan Chung. (2019) Future Risks in Patients With Severe Asthma. Allergy, Asthma & Immunology Research 11:6, pages 763.
Crossref
Crossref
Giorgio Walter Canonica, Giorgio Lorenzo Colombo, Giacomo Matteo Bruno, Sergio Di Matteo, Chiara Martinotti, Francesco Blasi, Caterina Bucca, Nunzio Crimi, Pierluigi Paggiaro, Girolamo Pelaia, Giovanni Passalaqua, Gianenrico Senna, Enrico Heffler, Stefano Aliberti, Diego Bagnasco, Sarah Barbuto, Gianna Camiciottoli, Marco Caminati, Giselda Colombo, Teresa Costantino Maria, Claudia Crimi, Mariangiola Crivellaro, Mariella D'Amato, Elisabetta Favero, Pia Foschino Maria, Gabriella Guarnieri, Manuela Latorre, Carlo Lombardi, Francesco Menzella, Vincenzo Patella, Francesca Puggioni, Erminia Ridolo, Giovanni Rolla, Eleonora Savi, Nicola Scichilone, Paolo Solidoro, Giuseppe Spadaro & Massimo Triggiani. (2019) Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. World Allergy Organization Journal 12:1, pages 100007.
Crossref
Crossref
Pinkus Goldberg. 2019. Treatment of Asthma in Older Adults. Treatment of Asthma in Older Adults
53
69
.
Christer Janson, Karin Lisspers, Björn Ställberg, Gunnar Johansson, Gunilla Telg, Marcus Thuresson, Helene Nordahl Christensen & Kjell Larsson. (2018) Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids – a Swedish observational cohort study (PACEHR). Respiratory Research 19:1.
Crossref
Crossref
Timm Volmer, Timo Effenberger, Christoph Trautner & Roland Buhl. (2018) Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. European Respiratory Journal 52:4, pages 1800703.
Crossref
Crossref
Xuehua Ke, Abhishek Kavati, Debra Wertz, Qing Huang, Liya Wang, Vincent J. Willey, Judith J. Stephenson, Benjamin Ortiz, Reynold A. PanettieriJr,Jr, & Jonathan Corren. (2018) Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab. Clinical Therapeutics 40:7, pages 1140-1158.e4.
Crossref
Crossref
L. E. Barry, J. Sweeney, C. O’Neill, D. Price & L. G. Heaney. (2017) The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis. Respiratory Research 18:1.
Crossref
Crossref
Michael S. Blaiss, Mario Castro, Bradley E. Chipps, Myron Zitt, Reynold A. PanettieriJr.Jr. & Michael B. Foggs. (2017) Guiding principles for use of newer biologics and bronchial thermoplasty for patients with severe asthma. Annals of Allergy, Asthma & Immunology 119:6, pages 533-540.
Crossref
Crossref